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Lipoid pneumonia results from the pulmonary accumulation of endogenous or exogenous lipids.
Host tissue reactions to the inhaled substances differ according to their chemical characteris-
tics. Symptoms can vary significantly among individuals, ranging from asymptomatic to severe,
life-threatening disease. Acute, sometimes fatal, cases can occur, but the disease is usually
indolent. Possible complications include superinfection by nontuberculous mycobacteria,
pulmonary fibrosis, respiratory insufficiency, cor pulmonale, and hypercalcemia. The radiolog-
ical findings are nonspecific, and the disease presents with variable patterns and distribution.
For this reason, lipoid pneumonia may mimic many other diseases. The diagnosis of exogenous
lipoid pneumonia is based on a history of exposure to oil, characteristic radiological findings,
and the presence of lipid-laden macrophages on sputum or BAL analysis. High-resolution
computed tomography (HRCT) is the best imaging modality for the diagnosis of lipoid pneu-
monia. The most characteristic CT finding in LP is the presence of negative attenuation values
within areas of consolidation. There are currently no studies in the literature that define the
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660 E. Marchiori et al.discontinuing exposure to the offending agent. Treatment in patients without clinical symp-
toms remains controversial, but in patients with diffuse pulmonary damage, aggressive thera-
pies have been reported. They include whole lung lavage, systemic corticosteroids, and
thoracoscopy with surgical debridement.
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Several pulmonary complications may be caused by the
aspiration of different substances into the airways and
airspaces. Lipoid pneumonia (LP) is an uncommon condition
that results from the pulmonary accumulation of fatlike
compounds of animal, vegetable or mineral origin.1,2 It can
be classified into endogenous and exogenous forms.
In endogenous form, also called “cholesterol” or
“golden” pneumonia, the fatlike materials are derived from
the lung itself.3,4 It usually develops when lipids that nor-
mally reside in the lung tissue emost commonly cholesterol
and its esters e are released from destroyed alveolar cell
walls distal to an obstructive airway lesion or from lung
tissue damaged by a suppurative process, or due to lipid
storage diseases.3,5,6
The exogenous form can be classified into acute and
chronic. Chronic exogenous LP results from long-term,
recurrent inhalation exposure to oil, while the acute form is
secondary to accidental aspiration of a large quantity of
lipid material over a short period of time.7,8
Etiopathogenesis and pathophysiology
Exogenous LP is caused by the inhalation of oils present in
food, radiographic contrast media, or oil-based medica-
tions such as laxatives.1,9 Traditional oil-based popular
medicines are used to treat various diseases in children,
and are often associated with respiratory diseases.10 In
adults, most cases result from the use of oil-based laxatives
(olive oil, cod liver oil and paraffin oil) for the treatment of
constipation, followed by the nasal instillation of oily
products for chronic rhinopharyngeal diseases.3,11Chronic constipation is a frequent symptom in the pedi-
atric population.Mineral oil is also used in children for partial
small bowel obstruction by Ascaris lumbricoides.12,13
However, it must be remembered that infants and small
children often object vigorously to ingest the oil, resulting in
gagging that precipitates aspiration.14
Different substances called pyrofluids are used by “fire-
eaters” (performers that “swallow” or “spit” fire). The most
common is the petroleum-derivative kerdan, characterizedby
its reduced viscosity and rapid diffusion throughout the bron-
chial tree. After flame blowing, the fire-eater takes a deep
breath, and can aspirate the kerdan remaining in the mouth.8
It is noteworthy that fire-eater pneumonitis has morpho-
logical, radiographic and clinical profiles entirely different
from chronic lipoid pneumonia. The history of accidental
aspiration during “fire-eating” demonstrations is character-
istic. Symptoms occur in the first 12 h after aspiration, and
include chest pain, dyspnea, cough, fever, and hemoptysis.
The disease has, in most of cases, a favorable evolution. The
HRCT usually shows bilateral lung consolidations, often
associated with cavitary lesions (pneumatoceles).8
Other less commonly reported causes of LP include:
aspiration of milk,15,16 poppy seed oil,3 and egg yolk16;
occupational exposure to paraffin (paraffin droplets
released by machines) in cardboard crockery factories17; oil
blasting in industries; use of spray paint18; contact with
plastic paint19; aspiration of oils used in industry as lubri-
cants and cutting fluids, in either fluid or spray form, for
turning, milling and grinding operations3; cleaning of new
cars protected by paraffin, using hot water generated by
compressed air jets20; cleaning oil-containing vats;
siphoning diesel fuel19,21; smoking blackfat tobacco, a Ken-
tucky product coated with oil and petroleum jelly to flavor
and moisturize the leaf6; accidental aspiration of vaseline
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use of petroleum jelly (Vaseline, Vicks) at bedtime23;
aspiration of spray lubricant WD-40 (very popular oil spray,
for home use)24; excessive use of lip balm (Chap Stick,
a lipstick that contains petrolatums and lipids) and of
flavored lip gloss6; and facial application of petrolatum for
erythrodermic psoriasis.25 Some authors also described the
development of LP secondary to suicide attempt by mineral
oil immersion.21,26
Factors that increase the risk of exogenous LP include
extremes of age; anatomical or structural abnormalities of the
pharynx and esophagus, such as Zenker diverticulum, gastro-
esophageal fistula, hiatal hernia, gastroesophageal reflux,
achalasia; psychiatric disorders; episodes of loss of
consciousness; neuromuscular disorders that result in swal-
lowingdysfunctionor affect thecough reflex; and,particularly
in children, forcedoil intake.1,7,27e29Because theyfloat on the
topof stomachfluids,oilsmayenter theairwaywhenaspirated
by patients with gastroesophageal reflux disease.3,6e8,27,30
Critically ill patients receiving nasoenteric feeding may
easily develop aspiration pneumonia, as a result of
a retrograde regurgitation of feeding solutions.31
In some countries the digestive form of Chagas disease,
where patients with megacolon have severe and prolonged
periods of constipation (over 60 days), should also be
remembered.32,33 The combination of two factors (con-
stipation caused by functional disorder of colon, and
tendency to aspiration due to megaesophagus) enhances the
risk of lipoid pneumonia in patients with Chagas disease.34
In many cases there is no predisposing condition and the
excessive use of oily substances is the presumed cause.1,2,29
In adults, 25% of cases of lipoid pneumonia occur in indi-
viduals without any predisposing factors.3,14
It is noteworthy that the aspiration of mineral oil usually
occurs unnoticed because it does not induce reactive
responses in the airways, such as glottic closure or cough.
These substances introduced into the nose can easily and
silently reach the bronchial tree of sleeping patients
without eliciting a normal protective cough reflex11 and
may impair mucociliary transport, subsequently reducing
their clearance from the respiratory tract.3,14Clinical findings
The clinical symptoms are nonspecific, and vary according
to the patient’s age, duration of oil intake, and the amount
and quality of oil aspirated.14,35
The time of exposure to oil varies widely in the cases
described in the literature, reaching up to several
years.3,7,8,30,36,37 In almost all studies, the amount of oil
consumed was not quantified.3,7,8,30,36,37
In the elderly, these pneumonias are usually chronic,
progressive, and asymptomatic. For this reason, it may be
discovered only as an incidental autopsy finding. Respira-
tory failure requiring ventilatory support is an unusual
presentation of the disease.21 In children, massive aspira-
tion may present with acute clinical manifestations and
early radiological findings.36,38
Symptoms can vary significantly among individuals, ranging
from asymptomatic to severe, life-threatening disease.39
When present, symptoms are usually mild.26 Lipoidpneumonia usually presents with chronic cough, sometimes
productive, and dyspnea.40 Less common problems include
chest pain, hemoptysis, weight loss, and intermittent fever.
Physical examination of the chest may be normal or may
presentdullness topercussion, crackles,wheezes,or rhonchi.6
Most cases of lipoid pneumonia shows a discrepancy in
severity between the radiological and clinical findings.
Patients are often asymptomatic with extensive imaging
findings, which are discovered incidentally on routine chest
radiographs.2,6,28
Extrathoracic symptoms, such as vomiting, stomach
pain, dysphagia, vertigo and fainting, are occasionally
described in the literature.8 The presence of hypertrophic
osteoarthropathy has been reported in a five-year-old child
with a history of forced feeding with animal fat (ghee).41
Since its clinical and radiological presentations are
nonspecific, lipoid pneumonia may mimic many other
diseases,14 especially bacterial pneumonia, presenting with
fever and cough.19 Occasionally, it can also simulate lung
tumours,42 pulmonary tuberculosis or cystic fibrosis43.
Diagnosis
The diagnosis of exogenous lipoid pneumonia is based on
a history of exposure to oil with radiological findings in
keeping with the disease and the presence of lipid-laden
macrophages on sputum or bronchoalveolar lavage (BAL)
analysis.3,28 It should be considered, however, that none of
these findings alone is diagnostic of lipoid pneumonia.
Clinical history
Exogenous lipoid pneumonias may be difficult to diagnose
because a history of oil ingestion is often missed. The
exposure is often identified only retrospectively after the
diagnosis is made, when a directed history is taken from
the patient or their parents.7,29,35,42
Bronchoalveolar lavage
Bronchoscopy with BAL has been reported to be successful
in establishing the diagnosis of lipoid pneumonia. It allows
the assessment of airway anatomy to rule out other causes
of chronic nonresolving pneumonia.1,14 Plugging with oil has
been noted bronchoscopically and on post-mortem exami-
nation.43 The macroscopic appearance of BAL may suggest
the diagnosis, revealing a whitish or turbid fluid, with fat
globules on the fluid surface.6,14,29 In a series of 10 children
with LP, Sias et al.44 have found that all of them showed
a milky BAL fluid on gross examination.
Besides the diagnostic value, BAL has therapeutic
implications in some cases.44 The biochemical analysis of
the collected fluid can help to confirm the diagnosis, when
using fat stains.45 The specific type of oil aspirated can be
determined by chemical analysis, infrared spectroscopy or
chromatography.6,44,46
The cytological demonstration of lipid-laden macrophages
is consistent with the diagnosis of exogenous LP,14 although
false-negative results may also occur.14 Both the presence of
lipid-ladenmacrophages per se (Fig. 1), and the finding of high
lipid-laden macrophage index (LLMI)47 are nonspecific
Figure 1 Alveolar macrophages recovered by bronchoalveo-
lar lavage. The cytoplasm is full of large rounded vacuoles that
displace the nucleus to the periphery (oil red O stain, 400).
Figure 2 Chest radiograph shows bilateral extensive
consolidations predominantly in central zones of the lungs.
Figure 3 HRCT at the level of the lower lobes demonstrates
areas of airspace consolidation with air bronchogram in both
lungs.
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there is no clinical evidence of aspiration.47e49 However, the
presence of extracellular oily droplets is more specific for
exogenous LP. Another finding that distinguishes exogenous
from endogenous LP is the presence of foamy macrophages
with large cytoplasmic vacuoles contrasting to small vacuoles
seen in the endogenous form.6,44 The computation of an LLMI
may be helpful in excluding aspiration as a cause of paren-
chymal lung disease.50
Midulla et al.35 reported marked reduction in normal
alveolar macrophages, slight increase in eosinophil
numbers and increased number of activated lymphocytes.
After oil intake ended, normal and lipid-laden macrophages
increased and lymphocyte numbers decreased.
Chest radiograph
The diagnostic accuracy of chest radiograph in aspiration
diseases is relatively low.11 More than half of the patients
with exogenous LP are asymptomatic on presentation, and
are only identified because of an abnormality seen on
a chest radiograph.2,6 The findings in lipoid pneumonia are
nonspecific,29 and the disease presents with variable
patterns and distribution, ranging from asymptomatic focal
inflammatory reaction with little or no radiological abnor-
mality to severe life-threatening disease.11,27,46
Diffuse and confluent consolidations (Fig. 2), bilateral
poorly-defined opacities, irregular mass-like lesions, bilat-
eral and symmetrical reticulonodular pattern, mixed alve-
olar and interstitial pattern, and unilateral or bilateral
nodular lesions may be seen.51 According to the literature
data, the abnormalities on chest radiographs are most
commonly observed in the lower and middle lobes.1,29,42
The upper lobes may also be affected. Alveolar lesions
either localized or diffuse, are the earliest changes.
Computed tomography
High-resolution computed tomographyis the best imaging
modality for establishing the diagnosis of lipoid pneumonia.42The most frequent findings are airspace consolidations
(Fig. 3), ground-glass opacities (Fig. 4), the crazy paving
pattern (Fig. 5), interlobular septal thickening, airspace
nodules (small poorly-defined centrilobular nodules), and
mass-like lesions1,7,27,28,37,52 (Fig. 6). None of these aspects
are a specific radiological feature of LP. In a study comparing
adults and children, Marchiori et al.37 demonstrated that the
consolidations were significantly more frequent in children,
while the crazy paving pattern was more commonly seen in
adults. The prevalence of ground-glass opacities or airspace
nodules did not differ between the two groups.
The most characteristic finding in LP is the presence of
consolidations with areas of fat attenuation, i.e., negative
attenuation values2,3,7,11,14,37 (Fig. 7). Bottled mineral oil
has a computed tomographic attenuation value of 132
Hounsfield units.6 However, the measured attenuation
values are higher than those of pure oil, as the oil is spreaded
within the affected parenchyma andmixedwith components
of pulmonary fibrosis and/or inflammatory exudates.52
Several authors have suggested that negative densities
valuesbetween150and30HUinsideareasofconsolidation
Figure 4 HRCT demonstrates extensive ground-glass opaci-
ties in both lungs, predominantly seen on the right lung.
Figure 6 HRCT demonstrates amass on the posterior segment
of the right upper lobe, with adjacent ground-glass opacities.
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with lipoid pneumonia,6,14,37,42,52,53 especially when associ-
ated with a history of exposure to oil.
However, care must be taken in obtaining these
measurements, in order to prevent a false-positive inter-
pretation. These measures should be taken in the most
hypodense part of the consolidation areas,2,28 free of any
aerated parenchyma on the periphery of the consolidation
or areas of air bronchogram, due to interferences caused by
partial-volume averaging of partly aerated lung.28,54,55 Air
and soft tissue, when averaged together, can mimic the
characteristic attenuation values of fat.3,7,10,39
Unlike the consolidations, the specificity of the finding
of fat in PL presenting as pulmonary nodules or masses is
much lower, since some tumors such as hamartoma and
lipoma may present with this finding. Moreover, the
differential diagnosis should also be done with tumors
originating from the pleura, mediastinum, or chest wall,
which include teratomas, thymolipomas, lipomas and
liposarcomas.56
The aspiration of different substances can cause symp-
toms similar to those of LP. These substances can produce
pulmonary consolidations resembling lipoid pneumonia, but
do not show areas of fat attenuation.Figure 5 HRCT shows areas of ground-glass attenuation in
the right upper lobe, superimposed on interlobular septal
thickening (crazy paving pattern). The left lung is normal.Histopathology
Needle aspiration biopsy has been used for the diagnosis of
LP.53 Cytological examination may be negative despite
chemical evidence in the sputum of oil expectoration.6 On
the failure of other methods, open lung biopsy may be
indicated, with the disadvantage of being a much more
invasive procedure.9,14
If the diagnosis remains uncertain, percutaneous fine-
needle aspiration biopsy, transbronchial biopsy or open
lung biopsy may be necessary.46 Kameswaran et al.57
reported that transbronchial biopsy may be helpful in
establishing the diagnosis, and suggested that open lung
biopsy should be reserved for those few cases where the
preceding less invasive methods are unhelpful.
The histological specimens cannot be embebbed into
paraffin, as the lipids are dissolved by xylol and other
substances used in the processing. Therefore the analysis is
limited to frozen sections. The diagnosis is made by usingFigure 7 HRCT scan at the level of the lower lobes with
mediastinal window shows consolidation with superimposed
areas of low attenuation (ranging from 31 to 116 HU) in the
right lower lobe (arrows).
Figure 8 Photomicrography shows the presence of lipid-
laden macrophages that fill the alveolar airspaces. Note also
macrophages inside the alveolar septa (original magnification,
40; hematoxilin-eosin stain).
664 E. Marchiori et al.dyes specific for lipids, where vacuoles are stained in
orange with Sudan III, brownish-orange with Sudan IV, and
deep red with Oil Red O. Sudan black B stains cholesterol
esters and triglycerides in dark blue, and some phospho-
lipids in gray.45
Histopathologically, chronic exogenous lipoid pneumonia
is characterized by the presence of lipid-laden macro-
phages that fill and distend the alveoli and interstitium,
where they may be associated with accumulation of lipid
material, inflammatory celular infiltration, and variable
amount of fibrosis1 (Fig. 8). Alveolar hemorrhage and
inflammatory exudate may be present.41
Complications
Superinfection of an exogenous lipoid pneumonia by non-
tuberculousmycobacteria is known, but rare.40,58 Exogenous
LP has been described in association with superinfection by
nontuberculous mycobacteria and occasionally by Nocardia
organisms.58 Lipids seem to enhance the growth of these
organisms, including Mycobacterium chelonei and Myco-
bacterium fortuitum, and impede their phagocytosis by the
hosts’ macrophages.14,40,58
Repetitive aspirations may result in variable amount of
pulmonary fibrosis,1 which can be severe when caused by
occupational exposure to paraffin17 Hypoxic respiratory
failure can also develop, occasionally leading to cor pulmo-
nale. A late-stage emphysematous appearance in adjacent
lungmay result from volume loss and retraction of the lesion.6
Another possible complication is hypercalcemia, probably
from inflammatory cells producing calcitriol, a phenomenon
observed in other granulomatous diseases such as sarcoid-
osis, tuberculosis, and systemic fungal diseases.6Treatment
There are currently no studies in the literature that define
the best therapeutic option. However, there is a consensusthat the key measure is identifying and discontinuing
exposure to the offending agent.3,7 It is important to
remember that the prevention in some workplaces is
essential. The various forms of exposure should be carefully
monitored by occupational physicians, especially when
paraffin may be aerosolized.17 Treatment is primarily
supportive and generally conservative, followed by the
treatment of complications.7,26
Other supportive measures, such as oxygen therapy,
respiratory therapy, control of risk factors, and mechanical
removal of intrapulmonary fat should be considered.4,6,14,42
It must be remembered that oil may be only a secondary
component of a commercial preparation, and one may be
misleaded when considering the substances to which the
patient was exposed.26
In children, the treatment of lipoid pneumonia is usually
supportive. The resolution of signs and symptoms occurs in
some months, after discontinuing the use of mineral oil. In
patients with diffuse pulmonary damage, aggressive ther-
apies have been reported.14
Whole lung lavage, sometimes used in the treatment of
patients with symptomatic alveolar proteinosis, may also
be therapeutic in treating LP.6,13,44 However, in some
cases, it seems that lipid phagocytosis by macrophages may
impede the removal by bronchial lavage.59
There are reports of systemic corticosteroids use to slow
the inflammatory response.5,60 However, steroid therapy
remains controversial, and should be reserved for severe
cases.5,59
Treatment in patients without clinical symptoms
remains controversial. Bronchiectasis caused by lipoid
pneumonia should be treated with aggressive early medical
management, but surgical resections designed to remove
the most affected portions of lung tissue is recommended
for those who do not respond to medical treatment.35Natural history and outcome
The natural history and outcome of LP are variable, and
depend on the type, volume, and distribution of oil aspi-
rated.59 With treatment, the majority of patients with an
acute presentation have clinical and radiographic improve-
ment, similar to the usual course of pneumonia.7 Information
about the course of lipoid pneumonia derives largely from
case reports, not long-term observational studies. Acute,
sometimes fatal, cases can occur, but the disease is usually
indolent.6 Some lesions may heal with fibrosis with subse-
quent loss of lung volume.5 If the patient discontinues the
exposure to the lipidic substances, both symptoms and
radiographic abnormalities may resolve within months, but
expectoration of oil may continue for years.6
It is important to recognize the various clinical and
radiological manifestations of LP, for prompt and accurate
diagnosis, resulting in decrease morbidity and mortality
rates. The best treatment for this disease is prevention.
Mineral oil laxatives are sold without prescription, and no
information is provided for consumers or clinicians on
possible hazards. It is suggested that changes in the
licensing of mineral oil for internal use may contribute
significantly to the primary prevention of LP. Health
professionals need to be aware of the risks and discourage
Exogenous lipoid pneumonia 665the uncontrolled use of mineral oil, especially for the very
young and the elderly.
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